STOCKHOLM, June 30, 2020 /PRNewswire/ -- Q-linea AB
(publ) ("Q-linea" or "the Company"), today announced that the
number of shares and votes in Q-linea has increased during the
month of June due to the direct issue of shares to certain Swedish
and international institutional investors and sector specialist
investors. The press release regarding the issue of shares was
published on 2 June 2020. A total of
4,000,000 ordinary shares and votes have been added.
At 30 June 2020, which is the last
trading day in June, the number of shares and votes in the Company
amounts to 27,337,947. All shares are ordinary shares.
This information is information that Q-linea AB (publ) is
obliged to make public pursuant to the Financial Instruments
Trading Act. The information was submitted for publication on
30 June 2020 at 08.30 AM CET
About Q-linea
Q-linea is an infection diagnostics company that primarily
develops instruments and disposables for rapid and reliable
infection diagnostics. Q-linea's vision is to help save lives by
ensuring antibiotics continue to be an effective treatment for
future generations. Q-linea develops and delivers preferred
solutions for healthcare providers, enabling them to accurately
diagnose and treat infectious disease in the shortest possible
time. The company's lead product ASTarĀ® is a fully automated
instrument for antibiotic susceptibility testing (AST), giving a
susceptibility profile within six hours directly from a positive
blood culture. For more information, please visit
www.qlinea.com.
For further information, please contact:
Anders Lundin, CFO and IR
Telephone: +46-706-00-15-20
E-mail: anders.lundin@qlinea.com
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/q-linea/r/change-in-the-number-of-shares-and-votes-in-q-linea-ab,c3142120
The following files are available for download:
https://mb.cision.com/Main/17731/3142120/1269913.pdf
|
Press Release
(PDF)
|